Device
1 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Post Stroke · Post-Traumatic Headache · Spinal Injuries · Cerebral Palsy, Spastic · Surgery · Sclerosis, Multiple · Spastic
Enrolment: 90 · Results not recorded
Bipolar Disorder
Enrolment: 13 · Results not recorded
Healthy Participants · Mild Cognitive Impairment
Enrolment: 91 · Results not recorded
Phobias · Claustrophobia · Social Phobia
Enrolment: 112 · Results not recorded
Hemiplegia
Enrolment: 25 · Results not recorded
Aging
Enrolment: 16 · Results not recorded
Alzheimer's Disease
Enrolment: 45 · Results not recorded
Autism
Enrolment: 30 · Results not recorded
Cognitive Decline · Cognitive Dysfunction · Alzheimer Disease · Vascular Disease, Peripheral
Enrolment: 24 · Results not recorded
Epilepsy
Enrolment: 80 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Controlled cortical impact through a 5 mm craniotomy over right parietotemporal cortex, 3 mm flat tip, rod speed 4.8 m/s, impact depth 2 mm, targeting a neurological severity score of 7 to 8 at 1 h
Single and especially 3 daily treatments improved neurological severity score and wire grip performance, reduced lesion size and Fluoro-Jade staining and increased bromodeoxyuridine positive cells, whereas 14 daily treatments gave no benefit over injured controls.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.
